• Sherica Celine
    Sherica Celine
    • 11 months ago
    • Practical Guidance Journal
    • pa

    Explore These Featured Additions to Practical Guidance

    Review this exciting guide to some of the recent content additions to Practical Guidance, designed to help you find the tools and insights you need to work more efficiently and effectively. Practical Guidance customers, please follow this link . Not...
  • Sherica Celine
    Sherica Celine
    • over 2 years ago
    • Practical Guidance Journal
    • pa

    Expungement and Reexamination Proceedings under the Trademark Modernization Act

    By: Jessica D. Bradley JONES DAY LLP This article discusses ex parte expungement and reexamination proceedings at the U.S. Patent and Trademark Office (USPTO). SUCH PROCEEDINGS SEEK FULL OR PARTIAL CANCELLATION of federal trademark registrations that...
  • Sherica Celine
    Sherica Celine
    • over 2 years ago
    • Practical Guidance Journal
    • pa

    Whistleblower Complaint Response and Defense Strategies under Section 11(c) of the Occupational Safety and Health Act

    By: Kenneth D. Kleinman and Brad M. Kushner, STEVENS & LEE This article addresses strategies for responding to and defending against whistleblower complaints filed under Section 11(c) of the Occupational Safety and Health Act (the OSH Act). 1 The...
  • Sherica Celine
    Sherica Celine
    • over 2 years ago
    • Practical Guidance Journal
    • pa

    Wage and Hour Issues Related to Remote and Hybrid Work: A Fertile Delta for Litigation

    By: Laurie E. Leader EDITOR-IN-CHIEF, BENDER’S LABOR AND EMPLOYMENT BULLETIN Everyone agrees that the COVID-19 pandemic has changed the way we work. Even as pandemic numbers wane, employers have continued to allow remote work schedules and hybrid...
  • Vinayak Kohli
    Vinayak Kohli
    • over 5 years ago
    • Practical Guidance Journal
    • pa

    Data Integrity Risk Management for Life Sciences Companies

    By: Scott Bass and Deeona Gaskin , Sidley Austin LLP This article addresses key topics related to the management of data by drug, biologic, and medical device companies whose products are regulated by the U.S. Food and Drug Administration (FDA). This...
<>